Daewon Pharmaceutical Market Cap

Daewon Pharmaceutical has a market cap or net worth of 219.26 billion as of April 10, 2026. Its market cap has decreased by -27.45% in one year.

Market Cap

219.26B

Enterprise Value

353.48B

Revenue

605.43B

Ranking

n/a

PE Ratio

n/a

Stock Price

10,300.00

Market Cap Chart

Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 219.26B, an increase of 1,114.09%. That is a compound annual growth rate of 10.45%.

Market Cap History

Date	Market Cap	% Change
Apr 9, 2026	219.26B	-14.39%
Dec 30, 2025	256.13B	-16.14%
Dec 30, 2024	305.43B	-7.98%
Dec 28, 2023	331.93B	-15.58%
Dec 29, 2022	393.20B	14.64%
Dec 30, 2021	343.00B	-9.91%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Hyundai Pharmaceutical	232.49B
HLB Pharmaceutical	230.86B
Chong Kun Dang Holdings	223.27B
Ilyang Pharmaceutical Co.,Ltd	220.84B
Samjin Pharmaceuticals	220.03B
Boditech Med	214.03B
Samil Pharmaceutical Co.,Ltd	203.80B
Suheung	203.23B

Market Cap Rankings